6 Promising Biopharmas With Major Catalysts in 2018 Post author:Sam Post published:January 28, 2018 Post category:BioPharma A look at six biopharma companies that may have major stock catalysts this year. Source: BioSpace You Might Also Like Arrogance and Greed: Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit January 1, 2018 Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity July 31, 2017 What You Need to Know About Fortis Therapeutics January 22, 2018
Arrogance and Greed: Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit January 1, 2018
Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity July 31, 2017
